Suchergebnisse - "Mortezaee, Keywan"

PubPharm (222)

31

The impact of hypoxia on extracellular vesicle secretome profile of cancer

enthalten in: Medical oncology | 2023

von Mortezaee, K. | Majidpoor, J.

32

The impact of hypoxia on extracellular vesicle secretome profile of cancer

enthalten in: Medical oncology | 2023

von Mortezaee, K. | Majidpoor, J.

33

Anti-PD-(L)1 therapy of non-small cell lung cancer-A summary of clinical trials and current progresses

enthalten in: Heliyon | 2023

von Mortezaee, K. | Majidpoor, J.

34

Bypassing anti-PD-(L)1 therapy : Mechanisms and management strategies

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Mortezaee, K. | Majidpoor, J. | Najafi, S. | +1

35

Transforming growth factor-β signalling in tumour resistance to the anti-PD-(L)1 therapy : Updated

enthalten in: Journal of cellular and molecular medicine | 2023

von Mortezaee, K. | Majidpoor, J.

36

Dysregulated metabolism : A friend-to-foe skewer of macrophages

enthalten in: International reviews of immunology | 2023

von Mortezaee, K. | Majidpoor, J.

37

Transforming growth factor‐β signalling in tumour resistance to the anti‐PD‐(L)1 therapy : Updated

enthalten in: Journal of Cellular and Molecular Medicine | 2023

von Mortezaee, K. | Majidpoor, J.

38

VISTA immune regulatory effects in bypassing cancer immunotherapy : Updated

enthalten in: Life sciences | 2022

von Mortezaee, K. | Majidpoor, J. | Najafi, S.

39

Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2022

von Rouzbahani, E. | Majidpoor, J. | Najafi, S. | +1

40

The impact of microbiota on PD-1/PD-L1 inhibitor therapy outcomes : A focus on solid tumors

enthalten in: Life sciences | 2022

von Najafi, S. | Majidpoor, J. | Mortezaee, K.